We use cookies for a better user experience. Read our Privacy Policy

I Agree

In-vitro Transcription Templates Market

In-vitro Transcription Templates Market (Disease: Cancer, Infectious Diseases, Lifestyle Diseases, Genetic Diseases, and Others; Treatment: Vaccine and Therapeutic; Research Stage: Exploratory and Clinical; and End User: Pharmaceutical & Biotechnology Companies, CROs & CMOs, Academics & Research, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

In-vitro Transcription Templates Witness Rise in Demand for R&D

The in-vitro transcription is a procedure that uses bacteriophage DNA-dependent RNA polymerase to synthesize RNA of any sequence from a DNA template. In-vitro transcription template reactions comprise an RNA polymerase promoter upstream of a series of interest. Synthesized RNA transcripts are further used for analyzing cellular RNA functionality in methods such as splicing, RNA processing, intracellular transport, viral infectivity, and translation. Advancements in biotechnology, including molecular biology and nanotechnology are significantly contributing to the expansion of the global in-vitro transcription templates market. The in-vitro transcription allows healthcare specialists to produce different sizes of RNA molecule ranging from milligram, microgram, and kilograms. Moreover, to perform multiple reactions to recognize biochemical processes of the human body, the formations of RNA molecules help researchers to identify it.

The in-vitro transcription templates market is witnessing massive investments in pharmaceutical and healthcare firms for research and development purposes. Research progresses in gene editing and drug formations required innovation and advanced transcription methods to study further, as these methods are utilized to introduce new drugs and results in the pharmaceutical industry. The increasing adoption of transcription methods to customize medications and drugs by healthcare providers is anticipating a surge in the demand for the in-vitro transcription templates market during the forecast period. Moreover, the rising prevalence of rare disorders, gene editing technology, and enabling targeted drugs with the use of RNA synthesis to stick to specific targets are some of the key factors contributing to the market growth in the upcoming future.

in vitro transcription templates market segmentation

Request a sample to get extensive insights into the In-vitro Transcription Templates Market

Need of In-vitro Transcribed RNA as Positive Control for Laboratory Diagnosis of COVID-19

The world continues to fight the disastrous effects of the ongoing COVID-19 pandemic. The extremely infectious nature of this respiratory condition hurdles high-level viral diagnostic technologies for speedy, scalable, affordable, and high precision testing. Molecular assays have been the gold criterion for immediate disclosure of the proximity of the viral RNA in suspected individuals. Moreover, immunoassays are being used in the examination of individuals by identifying antibodies against COVID-19. Improvements and developments in the biotechnology and pharmaceutical sectors are helping to produce the cure for COVID-19. The Messenger RNA or mRNA vaccines have secured the field with more agile production of new curative molecules. The rising necessity of Vitro transcriptions for the cure analysis of COVID-19 is increasing the demand for the in-vitro transcription templates market presently and is expected to further increase in the near future.

Vaccination producers such as Moderna presented their RNA vaccine candidate to NIAID for pre-clinical testing and launched a clinical trial by April 2020 with an immediate request to use models as a vaccine. The vaccine showed 95% effectiveness and excellent protection. Thus, following the research and hypothesis, the global in-vitro transcription templates market has grown resulting in rising production and distribution rate and increased efficiency and safety of the potential of mRNA therapy. Thus, the in-vitro transcription templates market is expanding even in the pandemic.

To understand how our report can bring difference to your business strategy, Ask for a brochure

High Demand Reducing Expenses for In-Vitro Transcription Templates

The present medical trends are moving toward synthetic RNA platforms, which enable accelerated, measurable, and cell-free production of preventive and therapeutic vaccines. The in-vitro transcription of antigen-encoding sequences or immunotherapies as synthetic RNA transcripts are in the expanding pipeline with the rising worldwide investments for its effectiveness. In-vitro transcribed mRNAs encoding viral antigens have been treated as a cure, while those encoding curative proteins have been examined for immunotherapy. The procedure is proving useful for treating various other infectious and severe diseases. Moreover, innovations and development in the medical technology are aiding in improved efficiency and outcomes. However, the expensive pricing for in-vitro transcription templates is hindering the growth rate, mostly in developing countries. The increasing production rates and demand for the market are expected to lower the prices, making it convenient for developing nations. Hence, the in-vitro transcription templates market is anticipated to grow in the developing countries during the forecast period,

Rise in Use of In-vitro Transcription Templates in Asia Pacific in Near Future

In-vitro transcription templates have been advanced and extensively used for several years to investigate the molecular mechanisms involved in transcription. Technological progress and procedures for targeting RNA include using the CRISPR-Cas9 genome editing technology, DNA-directed RNA intervention (ddRNAi) technology, and improved specific low molecular modulators for RNA or RNA-modifying enzymes. The recent years have witnessed new companies centering on the production of small-molecular RNA modulators. Applications of in-vitro transcription templates extend to multiple diseases, including neurological conditions and cancer. Emerging modifications and development are expected to provide alternative strategies to target RNA for drug development, which can result in propelling the global market. The global in-vitro transcription templates market is expected to expand at a CAGR of ~20% from 2021 to 2030.

The regional in-vitro transcription templates market is dominated by North America and currently holds the largest share. North America is expected to lead the future market, owing to the increase in demand for biopharmaceuticals such as vaccines and RNA-based therapeutics, peptides for the treatment of cancer, neurological diseases, and chronic kidney diseases. However, the demand for in-vitro transcription templates is expected to grow at a rapid pace due to rise in individual income, biotechnology, research institutes, and research funding by government and private bodies; expansion of healthcare infrastructure; large population base; and increase in the incidence of chronic and infectious diseases.

in vitro transcription templates market infographic

Stuck in a neck-to-neck competition with other brands? Request a custom report on In-vitro Transcription Templates Market

Analysts’ Viewpoint

In-vitro transcription helps researchers with the ability to synthesize RNA in the laboratory. The crucially important applications of in-vitro transcription templates for various infectious diseases, lifestyle diseases, genetic diseases, and others including cancer have tremendously driven the in-vitro transcription templates market. Investments by major businesses to sustain their position are likely to create significant opportunities in the market. Moreover, increasing adoption of technologically advanced products, rising patient population, and rapidly spreading of COVID-19 virus mutants are contributing to the growth of the global in-vitro transcription templates market. The heavy cost involved in the procedures is hindering the market growth in developing economies. However, due to rising government investments and influence of critical importance are helping in overcoming price barriers, resulting in a boost of the global in-vitro transcription templates market during the forecast period.

In-Vitro Transcription Templates Market: Overview

  • According to Transparency Market Research’s latest report on the global in-vitro transcription templates market for the historical period of 20182019 and forecast period of 20212030, increase in acceptance of personalized medicine by healthcare providers is projected to drive the global in-vitro transcription templates market
  • Growth of the global in-vitro transcription templates market can be attributed to increase in patient population with infectious diseases such as COVID-19 and cancer, rise in investment by pharmaceutical & biotechnology companies for drug discovery, and surge in preference for personalized medicine in developed as well as developing countries

Increase in Use of In-Vitro Transcription Templates in COVID-19 to Drive Market

  • Developments in the biopharmaceutical sector have intensified in the global race for the cure of COVID-19. Most importantly, messenger ribonucleic acid (mRNA) vaccines have galvanized the field with faster production of new therapeutic molecules.
  • For instance, Moderna submitted its RNA vaccine candidate to the National Institute of Allergy and Infectious Disease for pre-clinical testing. Moderna also launched its first clinical trial by April 2020, and requested Emergency Use Permission for its vaccine, after phase III trials, which showed 95% effectiveness and excellent protection.
  • Out of the 236 COVID-19 vaccines being produced, 29 are mRNA-based. These vaccines will be the first mRNA treatments to enter the market. Fast pace of mRNA vaccine production and high level of effectiveness and safety have brought to notice the significant potential of mRNA therapy. Hence, increase in use of mRNA in vaccine development drives the global in-vitro transcription templates market.

Surge in Emphasis of Healthcare and Pharmaceutical Firms on Strategic Collaborations, R&D, Drug Discovery, and Gene Editing Propels Global Market

  • Various pharmaceutical and biopharmaceutical companies have increased focus on research & development to find a cure or treatment for challenging disorders and diseases prevalent across the globe
  • Rise in focus of healthcare and pharmaceutical industries in R&D, drug development, and gene editing has led to increase in demand for innovative and sophisticated transcription tools for the launch of new products and drugs in the pharmaceutical industry. This is anticipated to propel the global in-vitro transcription templates market during the forecast period.
  • For instance, Biogen received the U.S FDA approval for Spinraza for the treatment of spinal muscular atropy in pediatric and adult patients. Spinraza is the first and only accepted medication in the U.S. for spinal muscular atrophy, the primary genetic cause of death in children and infants that is characterized by gradual, debilitating muscle weakness.
  • Numerous strategic alliances and partnerships have also been established between major pharmaceutical firms and biotech companies to exploit proprietary technology platforms, which boosts the growth of the global in-vitro transcription template market
  • Arbutus Biopharma Corporation, which owns LNP and ligand-conjugate distribution technologies, entered into a collaboration with Roivant Sciences to launch Genevan Sciences

High Cost of In-Vitro Transcription Templates to Hamper Global Market

  • The global in-vitro transcription templates devices market is technology driven. Introduction of new technologies in this market leads to improved efficiency and outcomes. This increases the demand for these templates. However, high cost retrains the in-vitro transcription templates market, especially in developing countries.
  • Novel technologies and modalities to target RNA comprise the application of CRISPR-Cas9 genome editing technology, DNA-directed RNA interference technology, and the development of discerning small-molecule modulators of RNA or RNA-modifying enzymes, which are more costly
  • Hence, high cost of in-vitro transcription templates is likely to hamper the growth of the market in the near future

In-Vitro Transcription Templates Market: Competition Landscape

  • This report profiles major players operating in the global in-vitro transcription templates market based on various attributes and recent developments
  • The global in-vitro transcription templates market is highly fragmented, with the presence of a large number of global as well as regional players
  • Leading players operating in the global in-vitro transcription templates market include
    • Thermo Fisher Scientific, Inc.
    • Promega Corporation
    • Agilent Technologies, Inc.
    • New England Biolabs
    • Takara Bio Inc.
    • Lucigen Corporation
    • Enzynomics Co. Ltd.
    • Enzo Life Sciences, Inc.
    • Cytiva (Danaher)

In-Vitro Transcription Templates Market: Key Developments

  • Key players in the global in-vitro transcription templates market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are aimed at addressing unmet needs in the in-vitro transcription templates market, strengthening the product portfolio, and investing in research & development. A few expansion strategies adopted by players operating in the global in-vitro transcription templates market are:
    • In December 2020, New England Biolabs launched NEBNext Custom RNA depletion design tool and RNA depletion core reagent set for customizable RNA depletion
    • In January 2020, Takara Bio and Tmunity entered into license agreement to advance siRNA technology to improve T cell therapies
    • In February 2019, Danaher entered into purchase agreement with GE for its Biopharma Business (Cytiva) for around US$ 21 Bn. On March 31, 2020, the acquisition was completed and Cytiva became a part of the Danaher Group. Cytiva is likely to be a standalone operating company within Danaher's life sciences segment.
  • The report on the global in-vitro transcription templates market discussed individual strategies, followed by company profiles of manufacturers of in-vitro transcription templates. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global in-vitro transcription templates market.

In-vitro Transcription Templates Market – Segmentation

Disease
  • Cancer
    • Solid Tumors
    • Colorectal Cancer
    • NSCLC
    • Melanoma
    • Leukemia
    • Prostate Cancer
    • Others
  • Infectious Diseases
    • Influenza
    • COVID-19
    • AIDS
    • Others
  • Lifestyle Diseases
  • Genetic Diseases
  • Others
Treatment
  • Vaccine
  • Therapeutic
Research Stage
  • Exploratory
  • Clinical
End User
  • Pharmaceutical & Biotechnology Companies
  • CROs & CMOs
  • Academics & Research
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of in-vitro transcription templates market?

In-vitro transcription templates market to reach valuation of ~US$ 900 Mn by 2030

What is the anticipated CAGR of the in-vitro transcription templates market in the forecast period?

In-vitro transcription templates market is expected to expand at a CAGR of ~20% from 2021 to 2030

What are the key driving factors for the growth of the in-vitro transcription templates market?

In-vitro transcription templates market is driven by increase in R&D funding in healthcare and biotechnology and rise in technological advancements in molecular biology

Which region is expected to project the highest market share in the global in-vitro transcription templates market?

North America dominated the global in-vitro transcription templates market and the trend is likely to continue during the forecast period

Who are the key players in the global in-vitro transcription templates market?

Key players in the global in-vitro transcription templates market include Thermo Fisher Scientific, Inc., Promega Corporation, Agilent Technologies, Inc., New England Biolabs, Takara Bio Inc., Lucigen Corporation, Enzynomics Co. Ltd., Enzo Life Sciences, Inc. and Cytiva (Danaher)

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global In-vitro Transcription Templates Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Disease Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global In-vitro Transcription Templates Market Analysis and Forecast, 2017–2031

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Technological Advancements

        5.2. Major Research Institutes Involved

        5.3. Disease Prevalence & Incidence Rate globally with key countries

        5.4. Number of mRNA Templates utilized Per Year

        5.5. Analysis of Purchase Criteria (vaccine/therapeutics/research)

            5.5.1. Overview of Purchase Criteria

            5.5.2. mRNA Size Needs

            5.5.3. Synthesis Scale Needs

            5.5.4. Modified Bases Needs

            5.5.5. cGMP/21 CFR part 11 certification requirement assessment

        5.6. COVID-19 Pandemic Impact on Industry (value chain and short / mid /long term impact)

    6. Global In-vitro Transcription Templates Market Analysis and Forecast, by Disease 

        6.1. Introduction & Definition

            6.1.1. Key Findings / Developments

        6.2. Global In-vitro Transcription Templates Market Value Forecast, by Disease, 2017–2031

            6.2.1. Cancer

                6.2.1.1. Solid Tumors

                6.2.1.2. Colorectal Cancer

                6.2.1.3. NSCLC

                6.2.1.4. Melanoma

                6.2.1.5. Leukemia

                6.2.1.6. Prostate Cancer

                6.2.1.7. Others

            6.2.2. Infectious Diseases

                6.2.2.1. Influenza

                6.2.2.2. COVID-19

                6.2.2.3. AIDS

                6.2.2.4. Others

            6.2.3. Lifestyle Diseases

            6.2.4. Genetic Diseases

            6.2.5. Others

        6.3. Global In-vitro Transcription Templates Market Attractiveness Analysis, by Disease 

    7. Global In-vitro Transcription Templates Market Analysis and Forecast, by Treatment 

        7.1. Introduction & Definition

            7.1.1. Key Findings / Developments

        7.2. Global In-vitro Transcription Templates Market Value Forecast, by Treatment, 2017–2031

            7.2.1. Vaccine

            7.2.2. Therapeutic

        7.3. Global In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment 

    8. Global In-vitro Transcription Templates Market Analysis and Forecast, by Research Stage 

        8.1. Introduction & Definition

            8.1.1. Key Findings / Developments

        8.2. Global In-vitro Transcription Templates Market Value Forecast by Research Stage, 2017–2031

            8.2.1. Exploratory

            8.2.2. Clinical

        8.3. Global In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage 

    9. Global In-vitro Transcription Templates Market Analysis and Forecast, by End-user 

        9.1. Introduction & Definition

            9.1.1. Key Findings / Developments

        9.2. Global In-vitro Transcription Templates Market Value Forecast, by End-user, 2017–2031

            9.2.1. Pharmaceutical & Biotechnology Companies

            9.2.2. CROs & CMOs

            9.2.3. Academics & Research

            9.2.4. Others

        9.3. Global In-vitro Transcription Templates Market Attractiveness Analysis, by End-user

    10. Global In-vitro Transcription Templates Market Analysis and Forecast, by Region

        10.1. Key Findings

        10.2. Global In-vitro Transcription Templates Market Value Forecast, by Region

            10.2.1. North America 

            10.2.2. Europe 

            10.2.3. Asia Pacific 

            10.2.4. Latin America 

            10.2.5. Middle East & Africa 

        10.3. Global In-vitro Transcription Templates Market Attractiveness Analysis, by Country/Region

    11. North America In-vitro Transcription Templates Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. North America In-vitro Transcription Templates Market Value Forecast by Disease, 2017–2031

            11.2.1. Cancer

                11.2.1.1. Solid Tumors

                11.2.1.2. Colorectal Cancer

                11.2.1.3. NSCLC

                11.2.1.4. Melanoma

                11.2.1.5. Leukemia

                11.2.1.6. Prostate Cancer

                11.2.1.7. Others

            11.2.2. Infectious Diseases

                11.2.2.1. Influenza

                11.2.2.2. COVID-19

                11.2.2.3. AIDS

                11.2.2.4. Others

            11.2.3. Lifestyle Diseases

            11.2.4. Genetic Diseases

            11.2.5. Others

        11.3. North America In-vitro Transcription Templates Market Value Forecast, by Treatment, 2017–2031

            11.3.1. Vaccine

            11.3.2. Therapeutic

        11.4. North America In-vitro Transcription Templates Market Value Forecast, by Research Stage, 2017–2031

            11.4.1. Exploratory

            11.4.2. Clinical

        11.5. North America In-vitro Transcription Templates Market Value Forecast, by End-user, 2017–2031

            11.5.1. Pharmaceutical & Biotechnology Companies

            11.5.2. CROs & CMOs

            11.5.3. Academics & Research

            11.5.4. Others

        11.6. North America In-vitro Transcription Templates Market Value Forecast, by Country, 2017–2031

            11.6.1. U.S.

            11.6.2. Canada

        11.7. North America In-vitro Transcription Templates Market Attractiveness Analysis 

            11.7.1. By Disease

            11.7.2. By Treatment 

            11.7.3. By Research Stage 

            11.7.4. By End-user 

            11.7.5. By Country

    12. Europe In-vitro Transcription Templates Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Europe In-vitro Transcription Templates Market Value Forecast, by Disease, 2017–2031

            12.2.1. Cancer

                12.2.1.1. Solid Tumors

                12.2.1.2. Colorectal Cancer

                12.2.1.3. NSCLC

                12.2.1.4. Melanoma

                12.2.1.5. Leukemia

                12.2.1.6. Prostate Cancer

                12.2.1.7. Others

            12.2.2. Infectious Diseases

                12.2.2.1. Influenza

                12.2.2.2. COVID-19

                12.2.2.3. AIDS

                12.2.2.4. Others

            12.2.3. Lifestyle Diseases

            12.2.4. Genetic Diseases

            12.2.5. Others

        12.3. Europe In-vitro Transcription Templates Market Value Forecast, by Treatment, 2017–2031

            12.3.1. Vaccine

            12.3.2. Therapeutic

        12.4. Europe In-vitro Transcription Templates Market Value Forecast, by Research Stage, 2017–2031

            12.4.1. Exploratory

            12.4.2. Clinical

        12.5. Europe In-vitro Transcription Templates Market Value Forecast, by End-user, 2017–2031

            12.5.1. Pharmaceutical & Biotechnology Companies

            12.5.2. CROs & CMOs

            12.5.3. Academics & Research

            12.5.4. Others

        12.6. Europe In-vitro Transcription Templates Market Value Forecast, by Country/Sub-region, 2017–2031

            12.6.1. Germany

            12.6.2. U.K.

            12.6.3. France

            12.6.4. Italy

            12.6.5. Spain

            12.6.6. Rest of Europe

        12.7. Europe In-vitro Transcription Templates Market Attractiveness Analysis 

            12.7.1. By Disease 

            12.7.2. By Treatment

            12.7.3. By Research Stage 

            12.7.4. By End-user 

            12.7.5. By Country/Sub-region

    13. Asia Pacific In-vitro Transcription Templates Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Asia Pacific In-vitro Transcription Templates Market Value Forecast, by Disease, 2017–2031

            13.2.1. Cancer

                13.2.1.1. Solid Tumors

                13.2.1.2. Colorectal Cancer

                13.2.1.3. NSCLC

                13.2.1.4. Melanoma

                13.2.1.5. Leukemia

                13.2.1.6. Prostate Cancer

                13.2.1.7. Others

            13.2.2. Infectious Diseases

                13.2.2.1. Influenza

                13.2.2.2. COVID-19

                13.2.2.3. AIDS

                13.2.2.4. Others

            13.2.3. Lifestyle Diseases

            13.2.4. Genetic Diseases

            13.2.5. Others

        13.3. Asia Pacific In-vitro Transcription Templates Market Value Forecast, by Treatment, 2017–2031

            13.3.1. Vaccine

            13.3.2. Therapeutic

        13.4. Asia Pacific In-vitro Transcription Templates Market Value Forecast, by Research Stage, 2017–2031

            13.4.1. Exploratory

            13.4.2. Clinical

        13.5. Asia Pacific In-vitro Transcription Templates Market Value Forecast, by End-user, 2017–2031

            13.5.1. Pharmaceutical & Biotechnology Companies

            13.5.2. CROs & CMOs

            13.5.3. Academics & Research

            13.5.4. Others

        13.6. Asia Pacific In-vitro Transcription Templates Market Value Forecast, by Country/Sub-region, 2017–2031

            13.6.1. Japan

            13.6.2. China

            13.6.3. India

            13.6.4. Australia & New Zealand

            13.6.5. Rest of Asia Pacific

        13.7. Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis 

            13.7.1. By Disease 

            13.7.2. By Treatment 

            13.7.3. By Research Stage 

            13.7.4. By End-user

            13.7.5. By Country/Sub-region

    14. Latin America In-vitro Transcription Templates Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Latin America In-vitro Transcription Templates Market Value Forecast, by Disease, 2017–2031

            14.2.1. Cancer

                14.2.1.1. Solid Tumors

                14.2.1.2. Colorectal Cancer

                14.2.1.3. NSCLC

                14.2.1.4. Melanoma

                14.2.1.5. Leukemia

                14.2.1.6. Prostate Cancer

                14.2.1.7. Others

            14.2.2. Infectious Diseases

                14.2.2.1. Influenza

                14.2.2.2. COVID-19

                14.2.2.3. AIDS

                14.2.2.4. Others

            14.2.3. Lifestyle Diseases

            14.2.4. Genetic Diseases

            14.2.5. Others

        14.3. Latin America In-vitro Transcription Templates Market Value Forecast, by Treatment, 2017–2031

            14.3.1. Vaccine

            14.3.2. Therapeutic

        14.4. Latin America In-vitro Transcription Templates Market Value Forecast, by Research Stage, 2017–2031

            14.4.1. Exploratory

            14.4.2. Clinical

        14.5. Latin America In-vitro Transcription Templates Market Value Forecast, by End-user, 2017–2031

            14.5.1. Pharmaceutical & Biotechnology Companies

            14.5.2. CROs & CMOs

            14.5.3. Academics & Research

            14.5.4. Others

        14.6. Latin America In-vitro Transcription Templates Market Value Forecast, by Country/Sub-region, 2017–2031

            14.6.1. Brazil

            14.6.2. Mexico

            14.6.3. Rest of Latin America

        14.7. Latin America In-vitro Transcription Templates Market Attractiveness Analysis 

            14.7.1. By Disease 

            14.7.2. By Treatment 

            14.7.3. By Research Stage 

            14.7.4. By End-user 

            14.7.5. By Country/Sub-region

    15. Middle East & Africa In-vitro Transcription Templates Market Analysis and Forecast

        15.1. Introduction

            15.1.1. Key Findings

        15.2. Middle East & Africa In-vitro Transcription Templates Market Value Forecast, by Disease, 2017–2031

            15.2.1. Cancer

                15.2.1.1. Solid Tumors

                15.2.1.2. Colorectal Cancer

                15.2.1.3. NSCLC

                15.2.1.4. Melanoma

                15.2.1.5. Leukemia

                15.2.1.6. Prostate Cancer

                15.2.1.7. Others

            15.2.2. Infectious Diseases

                15.2.2.1. Influenza

                15.2.2.2. COVID-19

                15.2.2.3. AIDS

                15.2.2.4. Others

            15.2.3. Lifestyle Diseases

            15.2.4. Genetic Diseases

            15.2.5. Others

        15.3. Middle East & Africa In-vitro Transcription Templates Market Value Forecast, by Treatment, 2017–2031

            15.3.1. Vaccine

            15.3.2. Therapeutic

        15.4. Middle East & Africa In-vitro Transcription Templates Market Value Forecast, by Research Stage, 2017–2031

            15.4.1. Exploratory

            15.4.2. Clinical

        15.5. Middle East & Africa In-vitro Transcription Templates Market Value Forecast, by End-user, 2017–2031

            15.5.1. Pharmaceutical & Biotechnology Companies

            15.5.2. CROs & CMOs

            15.5.3. Academics & Research

            15.5.4. Others

        15.6. Middle East & Africa In-vitro Transcription Templates Market Value Forecast, by Country/Sub-region, 2017–2031

            15.6.1. GCC Countries

            15.6.2. South Africa

            15.6.3. Rest of Middle East & Africa

        15.7. Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis 

            15.7.1. By Disease 

            15.7.2. By Treatment 

            15.7.3. By Research Stage 

            15.7.4. By End-user 

            15.7.5. By Country/Sub-region

    16. Competition Landscape

        16.1. Market Player - Competition Matrix (by tier and size of companies)

        16.2. Market Share Analysis by Company, 2020

        16.3. Company Profiles

            16.3.1. Thermo Fisher Scientific, Inc.

                16.3.1.1. Company Overview

                16.3.1.2. Company Financials

                16.3.1.3. Growth Strategies

                16.3.1.4. SWOT Analysis

            16.3.2. Promega Corporation

                16.3.2.1. Company Overview

                16.3.2.2. Growth Strategies

                16.3.2.3. SWOT Analysis 

            16.3.3. Agilent Technologies, Inc.

                16.3.3.1. Company Overview

                16.3.3.2. Company Financials

                16.3.3.3. Growth Strategies

                16.3.3.4. SWOT Analysis

            16.3.4. New England Biolabs

                16.3.4.1. Company Overview

                16.3.4.2. Growth Strategies

                16.3.4.3. SWOT Analysis 

            16.3.5. Takara Bio Inc.

                16.3.5.1. Company Overview

                16.3.5.2. Company Financials

                16.3.5.3. Growth Strategies

                16.3.5.4. SWOT Analysis

            16.3.6. Lucigen Corporation

                16.3.6.1. Company Overview

                16.3.6.2. SWOT Analysis 

            16.3.7. Enzynomics Co. Ltd.

                16.3.7.1. Company Overview

                16.3.7.2. SWOT Analysis 

            16.3.8. Enzo Life Sciences, Inc.

                16.3.8.1. Company Overview

                16.3.8.2. SWOT Analysis 

            16.3.9. Cytiva (Danaher)

                16.3.9.1. Company Overview

                16.3.9.2. Company Financials

                16.3.9.3. Growth Strategies

                16.3.9.4. SWOT Analysis 

    List of Table

    Table 01: Global In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Disease, 2017–2031

    Table 02: Global In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Cancer, 2017–2031

    Table 03: Global In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Infectious Diseases, 2017–2031

    Table 04: Global In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

    Table 05: Global In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Research Stage, 2017–2031

    Table 06: Global In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 07: Global In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 08: North America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 09: North America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Disease, 2017–2031

    Table 10: North America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Cancer, 2017–2031

    Table 11: North America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Infectious diseases, 2017–2031

    Table 12: North America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

    Table 13: North America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Research Stage, 2017–2031

    Table 14: North America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 15: Europe In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 16: Europe In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Disease, 2017–2031

    Table 17: Europe In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Cancer, 2017–2031

    Table 18: Europe In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Infectious diseases, 2017–2031

    Table 19: Europe In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

    Table 20: Europe In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Research Stage, 2017–2031

    Table 21: Europe In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 22: Asia Pacific In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 23: Asia Pacific In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Disease, 2017–2031

    Table 24: Asia Pacific In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Cancer, 2017–2031

    Table 25: Asia Pacific In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Infectious diseases, 2017–2031

    Table 26: Asia Pacific In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

    Table 27: Asia Pacific In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Research Stage, 2017–2031

    Table 28: Asia Pacific In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 29: Latin America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 30: Latin America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Disease, 2017–2031

    Table 31: Latin America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Cancer, 2017–2031

    Table 32: Latin America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Infectious diseases, 2017–2031

    Table 33: Latin America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

    Table 34: Latin America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Research Stage, 2017–2031

    Table 35: Latin America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 36: Middle East & Africa In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 37: Middle East & Africa In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Disease, 2017–2031

    Table 38: Middle East & Africa In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Cancer, 2017–2031

    Table 39: Middle East & Africa In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Infectious Diseases, 2017–2031

    Table 40: Middle East & Africa In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

    Table 41: Middle East & Africa In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Research Stage, 2017–2031

    Table 42: Middle East & Africa In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    List of Figure

    Figure 01: Global In-vitro Transcription Templates Market Value (US$ Mn) Forecast, 2017–2031

    Figure 02: Global In-vitro Transcription Templates Market Value Share, by Disease, 2020

    Figure 03: Global In-vitro Transcription Templates Market Value Share, by Extraction Type, 2020

    Figure 04: Global In-vitro Transcription Templates Market Value Share, by Method, 2020

    Figure 05: Global In-vitro Transcription Templates Market Value Share, by End-user, 2020

    Figure 06: Global In-vitro Transcription Templates Market Value Share, by Region, 2020

    Figure 07: Global In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2020 and 2031

    Figure 08: Global In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2021–2031

    Figure 09: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Cancer, 2017–2031

    Figure 10: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Infectious Diseases, 2017–2031

    Figure 11: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Lifestyle Diseases, 2017–2031

    Figure 12: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Genetic Diseases, 2017–2031

    Figure 13: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Others, 2017–2031

    Figure 14: Global In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2020 and 2031

    Figure 15: Global In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2021–2031

    Figure 16: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Vaccine, 2017–2031

    Figure 17: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Therapeutic, 2017–2031

    Figure 18: Global In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2020 and 2031

    Figure 19: Global In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2021–2031

    Figure 20: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Exploratory, 2017–2031

    Figure 21: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Clinical, 2017–2031

    Figure 22: Global In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 23: Global In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 24: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2017–2031

    Figure 25: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by CROs & CMOs, 2017–2031

    Figure 26: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Academics & Research, 2017–2031

    Figure 27: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Others, 2017–2031

    Figure 28: Global In-vitro Transcription Templates Market Value Share Analysis, by Region, 2020 and 2031

    Figure 29: Global In-vitro Transcription Templates Market Attractiveness Analysis, by Region, 2021–2031

    Figure 30: North America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, 2017–2031

    Figure 31: North America In-vitro Transcription Templates Market Value Share Analysis, by Country, 2020 and 2031

    Figure 32: North America In-vitro Transcription Templates Market Attractiveness Analysis, by Country, 2021–2031

    Figure 33: North America In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2020 and 2031

    Figure 34: North America In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2021–2031

    Figure 35: North America In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2020 and 2031

    Figure 36: North America In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2021–2031

    Figure 37: North America In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2020 and 2031

    Figure 38: North America In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2021–2031

    Figure 39: North America In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 40: North America In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 41: Europe In-vitro Transcription Templates Market Value (US$ Mn) Forecast, 2017–2031

    Figure 42: Europe In-vitro Transcription Templates Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 43: Europe In-vitro Transcription Templates Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 44: Europe In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2020 and 2031

    Figure 45: Europe In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2021–2031

    Figure 46: Europe In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2020 and 2031

    Figure 47: Europe In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2021–2031

    Figure 48: Europe In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2020 and 2031

    Figure 49: Europe In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2021–2031

    Figure 50: Europe In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 51: Europe In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 52: Asia Pacific In-vitro Transcription Templates Market Value (US$ Mn) Forecast, 2017–2031

    Figure 53: Asia Pacific In-vitro Transcription Templates Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 54: Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 55: Asia Pacific In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2020 and 2031

    Figure 56: Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2021–2031

    Figure 57: Asia Pacific In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2020 and 2031

    Figure 58: Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2021–2031

    Figure 59: Asia Pacific In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2020 and 2031

    Figure 60: Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2021–2031

    Figure 61: Asia Pacific In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 62: Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 63: Latin America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, 2017–2031

    Figure 64: Latin America In-vitro Transcription Templates Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 65: Latin America In-vitro Transcription Templates Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 66: Latin America In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2020 and 2031

    Figure 67: Latin America In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2021–2031

    Figure 68: Latin America In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2020 and 2031

    Figure 69: Latin America In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2021–2031

    Figure 70: Latin America In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2020 and 2031

    Figure 71: Latin America In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2021–2031

    Figure 72: Latin America In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 73: Latin America In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 74: Middle East & Africa In-vitro Transcription Templates Market Value (US$ Mn) Forecast, 2017–2031

    Figure 75: Middle East & Africa In-vitro Transcription Templates Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 76: Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 77: Middle East & Africa In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2020 and 2031

    Figure 78: Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2021–2031

    Figure 79: Middle East & Africa In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2020 and 2031

    Figure 80: Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2021–2031

    Figure 81: Middle East & Africa In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2020 and 2031

    Figure 82: Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2021–2031

    Figure 83: Middle East & Africa In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 84: Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2021–2031

Google translate

Copyright © Transparency Market Research, Inc. All Rights reserved